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Introduction: The prevalence of obesity in children and adolescents is increasing 
worldwide, including in low and middle income countries (LMIC).  Childhood obesity is 
also associated with conditions like metabolic syndrome (MS) and non-alcoholic fatty 
liver disease (NAFLD).This study looks at the prevalence of these complications and 
the factors that predict for them in obese children. Finally the effectiveness of the 
interventions implemented is assessed. 
 
Methods: This is a retrospective cohort study with cross-sectional elements performed 
at Tygerberg Children’s Hospital.  Obese and morbidly obese children (under 18years) 
attending the endocrinology clinic over a 7year period (2008 to 2014) were included in 
the study. Demographic data, severity of obesity and data on possible predictive 
factors for MS and NAFLD were collected. 
 
Results: Obese (n=18) and morbidly obese (n=65) children were studied. MS occurred 
in 45.5 % of the study population. MS was significantly more common in the morbidly 
obese group (p = <0.001).  Possible NAFLD occurred in 63% with no significant 
difference in incidence between obese and morbidly obese children. No factors 
predicted the presence of MS or NAFLD in this group of obese children.  Factors 
predicting a decrease in BMI SDS were: BMI at presentation (p = 0.01), duration of 
follow-up (p = 0.01) and age at presentation (p = 0.08).   
Conclusion: MS and NAFLD are as prevalent in obese children seen at Tygerberg 
Children’s Hospital as demonstrated internationally.  The follow-up BMI findings 
suggest that in order to successfully manage childhood obesity in our setting, long-
term follow up and early intervention is required.  Weight loss after dietary and lifestyle 










Inleiding: Die voorkoms van obesiteit in kinders en tieners is wêreldwydaan die 
toeneem, insluitende in die lae-en middel-inkomste lande. Obesiteit in kinders word 
geassosieer met toestande soos metaboliese sindroom en nie-alkoholiese vetterige 
lewersiekte. Hierdie studie kyk na die voorkoms van die komplikasies en die faktore 
wat hierdie  komplikasies sal voorspel in vetsugtige kinders. Ten slotte word die 
doeltreffendheid van die intervensies wat geïmplementeer word beoordeel. 
 
Metodes: Dit is 'n terugwerkende kohort studie met deursnee-elemente wat by 
Tygerberg hospitaal gedoen is. Vetsugtige kinders (onder 18 jaar) wat die 
endokrinologie kliniek bygewoon het oor 'n tydperk van 7 jaar (2008-2014) is ingesluit 
in die studie.  Demografiese data, graad van vetsug en data oor moontlike 
voorspellende faktore vir metaboliese sindroom en nie-alkoholiese vetterige lewer 
siekte is ingesamel.  
 
Resultate: Vetsugtige (n = 18) en morbied vetsugtige (n = 65) kinders is bestudeer. 
Metaboliese sindroom is gevind in 45.5% van die studiepopulasie en is aansienlik meer 
algemeen in die morbied vetsugtige groep (p = <0.001). Moontlike nie-alkoholiese 
vetterige lewersiekteis gevind in 63% met geen beduidende verskil in voorkoms tussen 
vetsugtige en morbied vetsugtige kinders nie. Voorspellende faktore vir 'n suksesvolle 
uitkoms na intervensie was: liggaamsmassa-indeks by eerste besoek (p = 0.01), 
tydperk van opvolg (p = 0.01) en ouderdom by eerste besoek (p = 0.08). Geen 
voorspellende faktore vir die ontwikkeling van metaboliese sindroom of nie-alkoholiese 
vetterige lewersiekte is in die groep vetsugtige kinders gedemonstreer nie.  
 
Gevolgtrekking: Metaboliese sindroom en nie-alkoholiese vetterige lewer siekte is net 
so algemeen in vetsugtigekinders gesien by die Tygerberg hospitaal as wat 
internasionaal gedemonstreer word. Die bevindings dui daarop dat om vetsugtige 
kinders suksesvol te behandel daar vroeë intervensie moet plaasvind en dat hulle vir 
lang termyn opgevolg moet word. Kinders met ‘n hoër liggaamsmassa-indeks was 
meer geneig tot ‘n suksessvolle uitkoms na intervensie.  
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List of Abbreviations 
ALT: Alanine aminotransferase  
AST: Aspartate aminotransferase 
BMI: Body mass index 
BMI SDS: Body mass index standard deviation score 
BP: Blood pressure 
CRP: C-reactive protein 
CT: Computerised tomography 
ECM: Enterprise Content Management 
GGT: Gamma-glutamyl transferase 
HDL-C: High-density lipoprotein cholesterol 
ICD10: The International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision 
LDL-C: Low-density lipoprotein cholesterol 
LFTs: Liver function tests 
LMIC: Low and middle income countries 
MRI: Magnetic resonance imaging 
MS: Metabolic syndrome 
NAFLD: Non-alcoholic fatty liver disease 
NCEP: National Cholesterol Education Program 
NHANES: The National Health and Nutrition Examination Survey 
PWS: Prader-Willi syndrome 
SD: Standard deviation 
UK: United Kingdom 
USA: United States of America 
WC: Waist circumference 
WHO: World Health Organisation 





Adolescents: Girls between 11 and 18 years and boys between 12 and 18 years 
Body mass index (BMI): Individual’s weight (in kilograms) divided by the length or 
height (in meters) squared 
Hypertension: A systemic blood pressure above the 95th percentile for systolic or 
diastolic as per National High Blood Pressure Education Program (Using updated 
values from NHANES III – Appendix 2) 
Morbid Obesity: BMI of the patient above 99,6th percentile (2 ⅔ standard deviations) 
on UK BMI chart (Appendix 1) 
Obesity: BMI of the patient above the 98th percentile (2 standard deviations) on UK 
BMI chart (Appendix 1) 
Presumed non-alcoholic fatty liver disease (NAFLD): An elevation above the 
normal range (as provided by the NHLS laboratory) of at least one of the liver 
associated enzymes AST, ALT or GGT in obese patients without another cause for 
liver disease 
Screen time: Amount of time per day spent on non-academic activities using an 
electronic device with a screen e.g. television, computer, tablet, cellphone.  
Sedentary lifestyle:  A lifestyle with no or irregular physical activity that does not 
increase energy expenditure substantially above the resting level and includes 
activities such as sleeping, sitting, lying down, and watching television, and other forms 
of screen-based entertainment 
Type 2 Diabetes: In this study: An obese child with a fasting glucose >7mmol/l and/or 
random glucose >11,1mmol/l and/or >11,1mmol/l 2hrs after meal or glucose tolerance 
test 
Waist circumference (WC): A WC above the 90th percentile for gender and age is 
increased as interpreted in accordance with the values from the NHANES III study.  
The landmark for taking the waist circumference is the high point of the iliac crest in a 
standing position. (Appendix 3) 
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Chapter 1: Introduction 
 
The prevalence of obesity in children and adolescents is increasing worldwide. In 
Africa the number of children who are overweight or obese has nearly doubled since 
1990, increasing from 5.4 million to 10.3 million in 2016. [29] Childhood obesity is 
associated with significant health problems like insulin resistance and obstructive sleep 
apnoea and is an early risk factor for increased morbidity and mortality in adults. [11] 
As the prevalence of obesity increases, so too does the prevalence of the metabolic 
syndrome (MS).  MS prevalence ranges from 18 to 50% in obese paediatric patients. 
[12] 
Non-alcoholicfatty liver disease (NAFLD) is becoming the most common cause of liver 
disease in children and adolescents. [8] NAFLD is strongly associated with obesity and 
the MS and is seen as the hepatic manifestation thereof. [19] NAFLD can lead to liver 
inflammation, fibrosis, cirrhosis and even death. 
This study looks at the prevalence of MS and NAFLD in obese children and 
adolescents seen at Tygerberg Children’s Hospital. So far, little data is available for 
this or any other population group living in a low and middle income country (LMIC).  
This study also assesses the predictive factors for MS and NAFLD as well as the 
effectiveness of the interventions to manage obesity in this population.  
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Chapter 2: Literature Review 
 
South Africa is a country with challenges unique to low and middle income countries 
(LMIC). In LMIC infectious diseases complicated by HIV and malnutrition are the main 
causes of mortality and morbidity. In most LMIC faced with a large burden of poverty 
under nutrition is common, especially amongst children and adolescents. But over the 
last decades the prevalence of obesity is increasing dramatically especially in the 
middle and high income groups living in LMIC leading to a dual burden of disease 
caused by malnutrition. The increase in obesity has been ascribed to the ongoing 
economic and lifestyle changes in our country. [1] 
 
Childhood obesity is a growing problem globally.  Obesity was recently officially 
classified as a disease by the American Medical Association. In essence due to lifestyle 
and diet, obesity has become one of the most important public health problems 
worldwide.  In modern times lifestyles are more sedentary.  Add to that a high refined 
carbohydrate and saturated fat diet and an increase in weight and fat tissue is 
inevitable. Obesity related healthcare, already a large health burden, is set to increase 
in the future.  Comparing the data from the USA’s National Health Examination Survey 
(NHANES) 2009 to 2010 with the earlier data from the 1999 to 2000 survey, an 
increase in the percentage of overweight children was demonstrated.  There was a 5% 
increase in prevalence of overweight children aged 12 to 19 years, a 4% increase in 
ages 6 to 11 years and a 3.2% increase in ages 2 to 5 years. [2,3] Globally the same 
trend has been observed.  Even preschool children (under 5 years) have shown a 
marked increase in obesity over the 20 years from 1990 to 2010 of about 60%. [3] It 
was estimated that 6.7% of children were overweight or obese in 2010 compared to 
4.2% in 1990. [3] Recent estimations put the global number of obese preschool 
children at approximately 43 million.  This estimation was based on cross-sectional 
surveys performed on 144 countries using the 2006 World Health Organization (WHO) 
child growth charts. Using these charts, children with a BMI for age >2 Standard 
deviations (SD) above the mean, were regarded as overweight and >3 SD were obese. 
[3] 
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There are limited data concerning childhood obesity available from LMIC where the 
prevalence of obesity is lower but increasing at a more rapid rate than in high income 
countries. In a study, specifically looking at preschool children (<5 years age), 
Southern Africa ranked second amongst developing nations in the United Nations 
when looking at the prevalence of overweight children (defined as >2 SD weight-for-
age). [4] In this study 6.7% of preschool children were classified as overweight.  The 
prevalence was not evenly distributed amongst Southern African countries as data 
from South Africa was overrepresented and largely responsible for this high proportion.  
The highest prevalence was seen in North Africa mainly due to the data from Algeria, 
Egypt and Morocco. [4] A study, performed in 2006, looking at 10195 primary school 
children in 5 provinces in South Africa, 14% boys and 17.9% girls were found to be 
overweight.  Body mass index (BMI) was measured according to the Cole et al BMI 
chart of 2000.  Cole determined cut-off points for BMI for overweight and obesity 
among children. This was developed from a sample of 192727 international subjects. 
This data was used to predict the BMI at different ages that would result in an 
overweight (BMI 25 kg/m2) or obese (BMI 30 kg/m2) subject at theage of 18 years. This 
was done in an effort to standardise measurements and allow international 
comparisons. [5] In a recent systematic review of 10 sub-Saharan countries ranging 
from upper middle to low income countries the prevalence of overweight or obesity 
ranged from 0.9 to 36.5% in girls and 0.4 to 21.0% in boys ages 5 to 18 years. 
Overweight or obesity was strongly associated with socio-economic status with 
children from the highest socio-economic status groups having a 5.28 (95% CI 2.62-
10.66) greater risk of being overweight or obese. [24] The high prevalence of 
overweight and obesity is not isolated to LMIC in sub-Saharan Africa.  Studies from 
India demonstrated similar data. In the Indian study the prevalence of overweight and 
obesity was 19.3% which had increased from 16.3% over 5 years in children 1 to 18 
years. [25] 
 
Obesity can be divided into primary (simple) or secondary obesity.  Primary obesity is 
by definition not explained by any known genetic or metabolic defect and typically has 
increased height and accelerated bone maturation.  Secondary obesity can be caused 
by endocrine or genetic abnormalities and typically these patients have a short stature 
and delayed bone maturity. [6] In order to diagnose obesity, the body composition must 
be determined. Indirect measures to assess excess adipose tissue are used.  In the 
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clinical setting anthropometry and skin fold thickness is commonly used as they are 
inexpensive and readily available.  Direct means of measuring adipose tissue are not 
readily available and are expensive.  Hydrodensitometry is regarded as the gold 
standard.  Direct measures such as bioimpedence analysis, dual energy x-ray 
absorptiometry, computer tomography (CT) and magnetic resonance scanning (MRI) 
are also able to estimate adiposity but are mostly used in research settings. [6,7] The 
only methods that can accurately assess intra-abdominal fat are CT and MRI. The 
most commonly used anthropometry based method is the body mass index (BMI).  BMI 
has been proven an appropriate way to measure adiposity and correlates well to the 
percentage body fat. BMI is less effective in thin and/or athletic children where 
differences in BMI are largely due to fat-free mass. [7]The BMI correlation with body 
fat is not precise as BMI cannot distinguish between body fatness, muscle mass and 
skeletal mass.  Other ways of assessing obesity are weight for age and weight for 
length charts.  These measurements are not accurate as they do not take body 
composition and fat distribution into account. 
 
The classification using BMI was based on the UK charts as compiled by Cole et al in 
1995.  A measurement above the 98th centile (or 2 SD) is obese and above the 99,6th 
centile is morbidly obese (Appendix 1).  These BMI classifications can be confusing at 
times as USA versions have different nomenclature and definitions. The same patient 
that is classified as obese in the UK and at our clinic will be labeled as ‘overweight’ in 
the USA.  There is also no absolute cut-off for BMI in paediatrics as fat mass changes 
with age. The adult BMI classification (obese being BMI ≥30kg/m2) can therefore not 
be directly applied to children.  BMI is low in infancy, rises and peaks at about 1year 
age, falls in early childhood and rises again after 8 years. This is referred to as the 
obesity rebound. [21] In this study we made use of the standard deviation (BMI SDS) 
score when following and comparing BMI trends.  
 
Physical measurements such as waist circumference (WC) and waist to hip ratio can 
also be used in assessing obesity. WC is a marker for intra-abdominal fat and is tightly 
correlated with hepatic triglyceride content, elevated ALT, liver inflammation and 
fibrosis indicating non-alcoholic fatty liver disease. [8] WC also indicates higher relative 
risk for developing obesity associated complications like type 2 diabetes, 
dyslipidaemia, hypertension and cardiovascular disease.  This has been proven in 
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adults and children (dyslipidaemia and hypertension) [9].  In a paediatric study 
increased waist circumference and increased abdominal adipose tissue was related to 
a higher incidence of NAFLD. [10] 
 
In adults there are commonly used standardised criteria for defining and diagnosing 
metabolic syndrome (MS). The difficulty with making the diagnosis of MS in children is 
that there is no consensus on the diagnostic criteria that should be used.  Another 
problem is that not all general paeditricians are aware of the existence of this entity.  A 
commonly used definition is the National Cholesterol Education Program (Adult 
treatment panel [ATP] III).  In 2007, the International Diabetes Federation (IDF) 
attempted a definition of paediatric metabolic syndrome using age-specific diagnostic 
criteria. In practice at our endocrinology clinic at Tygerberg Children’s Hospital we use 
the National Cholesterol Education Program (NCEP) criteria for adolescents to 
diagnose MS. 
Current NCEP criteria define the MS as the presence of any three of the following five 
traits: 
- Abdominal obesity, defined as a waist circumference ≥90th percentile  
- Serum triglycerides ≥1,2 mmol/L  
- Serum HDL cholesterol <1 mmol/L  
- Blood pressure ≥90th percentile for age and length 
- Fasting plasma glucose (FPG) ≥5,6 mmol/L 
 
MS increases the risk of cardiovascular and various other complications. [11] Although 
MS is associated with obesity, this does not mean that it is a causative association as 
MS can also occur in lean children and adults. [11] Associations among blood 
pressure, obesity, and impaired glucose tolerance have been described since the 
1920’s. The associated occurrences of these conditions led to the recognition of them 
as a syndrome, Metabolic Syndrome, in 1988.  Widespread recognition of this 
syndrome followed. It was assumed at that time and later verified that the syndrome 
can be modified by changes in body weight and physical activity. [12] Among obese 
children, the prevalence of the MS is high and increases with worsening obesity.  A 
2004 USA based study of 439 obese, 31 overweight, and 20 normal-weight children 
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and adolescents (between 4 and 20 years) showed that MSwas present in 39% and 
50% of the moderately and severely obese subjects respectively. None of the 
overweight or normal weight children in this study had MS. [13] In a longitudinal study 
performed by the National Heart, Lung and Blood Institute it was demonstrated that 
obesity and increasing visceral fat were risk factors for developing childhood MS. The 
Growth and Health Study enrolled girls aged 9 and 10 years (n=1192) from USA and 
followed them for 10 years from 1988 to 1998. MS (defined by Adult treatment panel 
III criteria) was present in 0.2% at baseline.  At ages 18 to 19 years of age MS was 
present in 3.5% of black and 2.4% of white girls. For every increase of 1 cm in waist 
circumference the risk of developing metabolic syndrome increased by 7.4%. [14] 
 
The complications of MS and obesity are multiple. Two of the main complications are 
insulin resistance leading to type 2 diabetes and cardiovascular disease. Other obesity 
associated complications include: polycystic ovarian syndrome with infertility, 
gynaecomastia, growth acceleration, pseudo-Cushing’s, pseudotumorcerebri, 
obstructive sleep apnoea, cholelithiasis and orthopaedic related disorders like Blount’s 
disease and slipped capital femoral epiphysis. 
 
NAFLD is not part of the MS definition but is considered the hepatic manifestation 
thereof.The pathophysiology is not completely understood.  A combination of genetic 
and environmental factors is likely responsible for the development of NAFLD.  Insulin 
resistance plays a role in the processes leading to increased free fatty acid and 
triglyceride accumulation in the hepatocytes. The gold standard for making the 
diagnosis is a liver biopsy. NAFLD presents with a wide variety of pathologies. The 
pathology can range from simple fatty accumulation in the liver to non-alcoholic 
steatohepatitis which has been associated with liver fibrosis and cirrhosis in childhood 
and adolescences. [19,26] Although the exact cause of NAFLD is unknown, it is 
associated with obesity.  As obesity increases throughout the world, so NAFLD is 
increasing. In obese children NAFLD prevalence as high as 70 to 80% has been 
reported. [27] The exact prevalence is however not known and there is a paucity of 
data from LMIC concerning this disease.  
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Although the diagnosis is confirmed with liver biopsy, this is not feasible or indicated in 
the majority of cases. Various non-invasive diagnostic criteria have been explored 
which include analysis of liver enzymes and anti-inflammatory cytokine release 
analysis as well as imaging.  Imaging modalities include liver ultrasound, CT and MRI 
scanning. All these tests have their limitations with varying degrees of sensitivity and 
specificity.  CT (sensitivity 82%; specificity 100%) and MRI (sensitivity 100% and 
specificity 90.4%) are not feasible due to availability and cost. [18] Ultrasound is readily 
used but is operator-dependent and lacks the ability to objectively quantifying liver 
steatosis.  Ultrasound detects steatosis with high sensitivity only if more that 30% of 
hepatocytes are involved. [23] A 2008 study shows that a computerized calculated 
hepatorenal index could objectively quantify liver steatosis in cases where as little as 
5% of hepatocytes were affected.  Depending on the percentage of steatosis the 
sensitivity ranged from 90% to 100% with specificity between 90% and 93%. [23] This 
is not available at our institution.  Transient elastography (Fibroscan), which measures 
liver stiffness non-invasively, is used in identifying advanced fibrosis in patients with 
hepatitis B and hepatitis C. Recent studies show high sensitivity and specificity for 
identifying fibrosis in NAFLD, but it has a high failure rate in individuals with a higher 
BMI and is not specific to the cause of the fibrosis. [15] This is also not readily available 
at our institution. 
The diagnosis of NAFLD according to the American guidelines requires that  
- there is hepatic steatosis by imaging or histology, 
- there is no significant alcohol consumption, 
- there are no competing aetiologies for hepatic steatosis, and 
- there are no co-existing causes for chronic liver disease. 
 
Scoring systems like The NAFLD Fibrosis Score has been proposed in an attempt to 
more accurately diagnose advanced NAFLD non-invasively.  It is based on six readily 
available variables (age, BMI, hyperglycemia, platelet count, albumin, AST/ALT ratio).  
The score has a 67% sensitivity and 97% specificity for predicting advanced liver 
fibrosis and a 90% sensitivity and 60% specificity in excluding advanced fibrosis. [15] 
In our setting a screening test that is readily available, easy to perform and cost 
effective must be used. In our clinic any raised serum liver enzyme levels above normal 
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cut-off values (ALT, AST and/or GGT), in the absence of any other cause for liver 
damage, is seen as possible NAFLD. 
 
Serum alanine aminotransferase (ALT) has been studied as a screening for NALFD. 
[8] An Italian study in 2007 of 268 obese children looked at predictors of NAFLD.  ALT 
was found to be the most specific when compared to aspartate aminotransferase 
(AST), gamma-glutamyl-transferase (GGT), cholesterol, high-density lipoprotein 
(HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglycerides, uric acid, 
glucose, glucose during oral glucose tolerance testing, insulin, insulin during oral 
glucose tolerance testing, insulin resistance as estimated by homeostasis model 
assessment (HOMA) or C-reactive protein (CRP) as a single measurement.  The 
specificity of ALT was 81% at levels more than 30 U/L (95% CI 0.67 – 0.77) and 89% 
if more than 40 U/L (95% CI 0.6 – 0.7). Sensitivity ranged from 41 to 64% at the same 
corresponding levels. [16] The analyzer used in the study was not stated. A 2013 study 
from Hawaii, using patients aged 1-19 years being seen at their endocrinology clinic 
for suspected metabolic syndrome, used ALT as a screening parameter for liver 
disease in MS.  68% boys and 57% girls were found to havean elevated ALT.  In this 
study lower cut-off limits were used (25.8 U/L for boys and 22.1U/L for girls). [17] 
 
The degree of ALT elevation however does not correlate with the presence or severity 
of histological findings of NAFLD.  ALT cut-off values have also been debated.  The 
Screening ALT for Elevation in Today’s Youth (SAFETY) study done in America in 
2010 took results from 43 different USA hospitals with a total of 982 children aged 1-
17 years after excluding all children with liver disease, obesity and those using potential 
hepatotoxic medications.  This study found ALT cut-off values are set too high for the 
reliable detection of paediatric chronic liver disease and NAFLD. In the National Health 
and Nutrition Examination Survey (NHANES) study, the 95th percentile levels for ALT 
in healthy weight, metabolically normal, liver disease–free boys were 25.8 U/L and girls 
22.1 U/L. [18] NAFLD has widespread implications for healthcare.  NALFD is currently 
the most common cause of chronic liver disease in childhood and adolescence in the 
USA.  As obesity in the paediatric age group increases, NAFLD has become 
increasingly prevalent. [19] The question however remains if a similar situation exists 
in our clinic.  
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In addition to physical health concerns, obesity in childhood can also lead to social as 
well as psychological problems.  These include low self-esteem, depression, bullying, 
social isolation and discrimination. 
 
Simple obesity and with it MS is an almost entirely preventable disease.  When MS is 
present, lifestyle modification alone can be a very effective intervention. [28] The 
emphasis is on behavioural change, a calorie-controlled diet and increased physical 
activity.  Should comorbid conditions be present, then they must be treated 
appropriately.  Pharmacological intervention might be needed to control hypertension 
or type 2 diabetes.  Surgical interventions e.g. gastric binding or bypass might be 
required in extreme cases. 
 
Probably the most feasible option in our setting is a conservative approach of diet and 
exercise to obtain and maintain optimal weight. The importance of weight management 
to prevent progression of MS and its complications were demonstrated by the 
Coronary Artery Risk Development in Young Adults (CARDIA) study. In this 
observational study of 5115 young adults (ages 18 to 30 years), increasing BMI over 
15 years was associated with progression of MS components compared with young 
adults who maintained stable BMI over the study period, regardless of baseline BMI. 
[20] A 2012 systematic review on the effectiveness of lifestyle modifications in 
childhood obesity looked at data from 1975 to 2010.  38 Studies were included.  The 
results support the importance of lifestyle interventions as acritical part of treatment of 
childhood obesity.  Weight loss was greater when the duration of treatment was longer 
(>6 months).  Lifestyle interventions produced significant weight loss compared with 
no treatment control groups when looking at  BMI (-1.25kg/m2, 95% confidence interval 
[CI] -2.18 to -0.32; p = 0.008) and the BMI Z-score (-0.10, 95% CI-0.18 to -0.02; p = 
0.01).  Lifestyle interventions also produced significant improvement in triglyceride (p 
= 0.0003) and LDL-C (p = <0.0001), but not HDL-C (p = 0.22).  It is not clear whether 
the effects were due to the weight loss alone or attributable to the otheraspects of 
lifestyle intervention.  Comparing outcomes is difficult as there are various strategies 
of implementing dietary and activity changes.  [28] 
It is clear from the literature that childhood obesity is increasing in both highly 
developed countries as well as in LMIC. As the prevalence of obesity is increasing so 
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are MS and NAFLD. The increase in these complications associated with obesity has 
tremendous health implications in LMIC, where the health budgets are constrained by 
the economy. Early recognition and prevention of obesity and its complications are 
required.  To date, there is minimal data available on childhood obesity and MS with 
regards to the population in the Western Cape. This includes children attending our 
clinic at Tygerberg Children’s Hospital. It is important to establish the prevalence of MS 
and NAFLD in obese children in our setting and to determine whether dietary and 




















Chapter 3: Aim of the investigation 
3.1 Research justification: 
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From the literature review it is clear that the prevalence of obesity in children and 
adolescents is rising throughout the world.  The situation in low and middle income 
countries (LMIC) is no different than in other parts of the world and even children less 
than 5 years of age are becoming more obese. Obesity in children is associated with 
numerous well known complications including systemic hypertension, asthma, insulin 
resistance and dyslipidaemia resulting in increased morbidity and use of health 
facilities. [13] In contrast to adult patients the metabolic syndrome (MS) is less well 
recognised in children and adolescents.  The MS as diagnosed by clinical findings and 
laboratory results is in turn associated with non-alcoholic fatty liver disease (NAFLD). 
As obesity and the MS have increased in children worldwide so has the prevalence of 
NAFLD. NAFLD is now estimated to be the most common cause of chronic liver 
disease in children and adolescents. If not correctly managed NAFLD causes long-
term liver disease including liver fibrosis and cirrhosis. The impact that NAFLD has on 
health services in LMIC has not been estimated as there is a paucity of data concerning 
this disease. This study serves as a baseline study for our clinic at Tygerberg 
Children’s Hospital.  It documents the prevalence of MS and NAFLD in obese clinic 
patients from the population we serve.  It also measures the success of current 
management.  This data can then be used to compare future interventions.  Identifying 
factors which predict a drop in BMI could lead to modification of management practices 
and local guidelines.  
 
3.2 Research hypotheses: 
1. MS and NAFLD are common in obese children attending the paediatric 
endocrinology clinic at Tygerberg Children’s Hospital, Western Cape, South 
Africa. 
2. Lack of weight loss following dietary and lifestyle advice is predicted by a higher 
initial BMI, poor social circumstances and low income, number of caregivers 
and duration of follow-up. 
 
 
3.3 Research question: 
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What is the prevalence of the MS and NAFLD in obese children attending the paediatric 
endocrine clinic in a tertiary hospital in the Western Cape, South Africa and what is the 
effect on BMI of management strategies in the same clinic?  
 
3.4 Primary research objectives: 
1. To determine the prevalence of the MS in obese children attending the 
endocrine clinic in Tygerberg Children’s hospital. 
2. To determine the prevalence of possible NAFLD in obese children attending the 
endocrine clinic in Tygerberg Children’s hospital. 
3. To determine the change in BMI in response to dietary and lifestyle advice. 
 
3.5 Secondary objectives: 
1. To determine the prevalence of the MS in obese children and adolescents in 
different age bands(<2 years; 2 to 5 years; 5 to 18 years). 
2. To determine the prevalence of NAFLD in obese children and adolescents in 
different age bands(<2 years; 2 to 5 years; 5 to 18 years). 
3. To determine factors that predicts the presence of the MS. 
4. To determine factors that predicts the presence of possible NAFLD. 













Chapter 4: Methodology 





The study was carried out at the Tygerberg Children’s Hospital. The hospital is a 
tertiary care hospital situated in the Western Cape serving a population of 
approximately 1.5 million people. Of the children living in the Western Cape 10% live 
below the absolute poverty line. The majority of the children referred to the hospital 
come from impoverished communities. The hospital admits approximately 12000 
children per annum (2014) and 630 children were seen in the endocrinology outpatient 
service (2014).  
 
4.2 Study Design: 
Retrospective cohort study.   
 
4.3 Time frame: 
7 year period from January 2008 to December 2014. 
 
4.4 Study population: 
Children and adolescents younger than 18 years of age attending the endocrinology 
clinic at the Tygerberg Children’s Hospital were screened to see if they met the 
inclusion criteria of the study.  ICD10 codes E66.0, E66.8 and E66.9 were used to 
identify the patients. 
 
4.4.1: Inclusion Criteria: 
All patients identified from the paediatric endocrine clinic who were confirmed to be 
obese (BMI above 98th percentile or 2 standard deviations on UK BMI chart)) or 
morbidly obese (BMI above 99,6th percentile or 2 ⅔ standard deviations on UK BMI 
chart) were included in the study. 
  
 
4.4.2 Exclusion Criteria: 
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The following patients were excluded: 
- Prader-Willi syndrome (PWS) 
- other genetic conditions associated with obesity 
- untreated hypopituitarism  
- when the medical records of the patient could not be retrieved.  
 
4.5 Data collection: 
The data collected include the demographic data and relevant measurements: weight, 
height, BMI, and waist circumference (WC). Medical data included systemic blood 
pressure, data on co-morbid diseases and relevant special investigations. Relevant 
special investigations included serum enzymes indicative of liver disease 
(AST,ALT,GGT), serum triglyceride levels, blood glucose levels including fasting 
serum glucose and results of an oral glucose tolerance test if performed.  Body mass 
index standard deviation score (BMI SDS) was calculated at the first and last clinic visit 
of the collection period. BMI SDS was calculated using a UK based website. 
(http://www.phsim.man.ac.uk) 
 
4.6 Case definitions used: 
4.6.1 Obesity: BMI of the patient above the 98th percentile (>2 SD) on UK BMI chart 
(Appendix 1). 
4.6.2: Morbid Obesity: BMI of the patient above 99,6th percentile (>2 ⅔SD) on UK BMI 
chart (Appendix 1). 
4.6.3: Metabolic syndrome (MS): Using NCEP criteria for adolescents, MS is defined 
in the presence of any three of the following: 
- Abdominal obesity, defined as a WC ≥90th percentile for age 
- Serum triglycerides ≥1,2 mmol/L  
- Serum HDL cholesterol <1 mmol/L  
- Blood pressure ≥90th percentile for age and length 
- Fasting plasma glucose (FPG) ≥5,6 mmol/L 




4.6.4 Non-alcoholic fatty liver disease (NAFLD): Is diagnosed in the presence of 
obesity if one or more liver enzyme levels are elevated.  Enzymes used were AST, 
ALT and GGT and levels were according to the NHLS laboratory’s normal limits for 
age using the Siemens Advia 1800 analyser. 
 
4.7 Interventions: 
Patients were counselled on lifestyle at the clinic. This included exercise, diet and 
limiting screen time.  They were also seen by the dietician with advice on appropriate 
portions and a balanced meal. 
 
4.8 Data Management: 
The hospital’s patient database was searched for all pediatric patients with a diagnosis 
and ICD-10 code (E66.0, E66.8, E66.9) for obesity or morbid obesity.  The data 
sources were the medical records department, the clinic’s record system and the 
hospital’s Enterprise Content Management (ECM) system.  Data was captured on a 
case recording form (Appendix 4). Each case was allocated a unique case number 
which was used to protect the patient’s identity. The data was then transferred to an 
Excel spreadsheet for analysis. 
 
4.9 Data Analysis: 
Data analysis was done in collaboration with the Biostatistics Department at the 
University of Stellenbosch.  Stata version 14 was used to analyse the all the data.  A 
p-value <0.05 was considered as statistically significant. The outcome of prevalence 
of MS is described as a proportion and 95% confidence interval.  Predictors of MS 
were assessed in bivariate analysis using independent samples t-tests and Pearson’s 
chi square tests. Multivariable logistic regression analysis was used to assess the 
independent effects of the predictors.  In order to assess the effect of the intervention, 
to account for differing time of follow up, rates of change was computed for each 
individual by dividing the change in their standard deviation score over time by the time 
period of observation.  Rates were modelled using a Poisson regression analysis to 
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assess the effects of predictors such as number of siblings, income and other socio-
demographic risk factors.  
 
4.10 Ethical considerations: 
Ethical approval was obtained from the Committee for Human Research at the 
University of Stellenbosch.  Reference number S15/03/056. (Appendix 5) 
 
4.11 Limitations: 
A retrospective study like this relies on adequate documentation and clinical records 
by the attending medical doctors.  The most important limitation was the lack of data.  
This ranged from the necessary blood testing not being done to physical 
measurements not being taken e.g. waist circumference.  This is due to the lack of a 
standard clinical information form or protocol to guide doctors in training who rotate 
through the clinic. 
Not all 3 liver enzymes were done on all the patients therefore patients with possible 
NAFLD might have been missed. 
Another limitation with every retrospective study is that it assumed that measurements 
were taken correctly e.g. blood pressure being measured with the correctly sized cuff. 
Tanner staging was not recorded.  For this study puberty was defined by age.  
Assessment of pubertal onset by age is less accurate as there is considerable variation 
in the onset of puberty. 
The patients included are only those seen in our hospital clinic.  These patients are 
only from our drainage area which is a low income community. The findings of this 
study may therefore not be generalised to the population as a whole or to the more 
affluent strata of the society. 
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Chapter 5: Results 
 
Based on the ICD10 codes, 134 patients were found in the hospital database.  Of 
these, 44 were found not to match the study definition for obesity.  Of the remaining 
90, 7 were excluded from the study as one patient had Prader-Willi Syndrome (PWS) 
and 6 were diagnosed with untreated hypopituitarism.  The remaining 83 were included 
in the study. (See diagram 1)  
Of the 83 obese children 39 (47%) did not have all the parameters measured for 
diagnosing or excluding metabolic syndrome (MS).  The remaining 44 obese and 
morbidly obese children were used to examine the relationship of obesity and MS.  Of 
the 83 obese and morbidly obese patients included in the study, 15 (18%) did not have 
a waist circumference (WC) recorded, 2 patients did not have a WC greater than 90th 
percentile and 22 (26.5%) did not have liver functions performed.  This then left 44 
patients that were obese or morbidly obese with a recorded WC who also had liver 
functions done. 
Of the 83 obese and morbidly obese patients in the study 46 (55.4%) had at least one 
of the liver enzymes done.  Of these 29 (63%) were abnormal.  Of the 29 with abnormal 
LFT’s 4 were obese and 25 morbidly obese.  These patients were the study sample 
used to investigate the relationship between obesity and NAFLD. (See diagram 2) 
25 patients were preschool children of which 12 were under the age of 2 years. The 
average age was 7.7 years (8 months to 16 years 3 months).  Patient demographics 
are shown in Table 1. 
On presentation the meanBMI SDS was 3.39 with the median being 3.1. Figure 1 
demonstrates the distribution of the BMI SDS at presentation.  Table 2 illustrates the 
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Diagram 1: Flow diagram of patients studied to determine the relationship between 
obesity and metabolic syndrome 
 
n = 134 patients with Obese/Morbid obese ICD10 code 
 
 
44 patients with wrong 




n = 90 patients 
 
 
Excluded 7 patients: 1 with 




n = 83 patients used in study 
 
 
39 patients did not have 




n = 44 patients 
 
 
n = 20 patients with MS     n = 24 patients without MS 
 
 
n = 9 patients with abnormal LFTs 
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Diagram 2: Flow diagram of patients included in the study to determine the 
relationship between obesity and non-alcoholic fatty liver disease 
 
n = 83 patients 
 
 
37 patients with 
no LFTs done 
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Table 1: Demographics of enrolled patients 






<2 years 12 14.5 
2-5 years 14 16.8 
5-18 years* 57 68.7 
Gender Female 34 41.0 
Male 49 59.0 
Severity Morbidly obese 65 78.3 
Obese 18 21.7 
Race Coloured 59 71.1 
White 13 15.7 
Black 10 12.0 
Indian 1 1.2 
*Adolescents made up 18.1% (n=15) of all patients; Adolescents were defined by age: girls 11 to 18 













Fig 1: Distribution of BMI SDS at presentation 
 
There were 44 children with obesity and morbid obesity who had all the parameters 
measured to diagnose or exclude MS.  The mean age of this population was 7.5 
years(range = 8 months to 16 years 3 months).  Of these 44 children who met the 
criteria 20 (45.5%) had MS of which 14 were obese and 30 morbidly obese.  MS was 
present in 4 (28.5%) of obese and 16 (53.3%) of the morbidly obese patients (p = 
<0.001).  Of the 10 adolescents, where all the parameters were available, 5 (50%) had 
MS and they were all morbidly obese. All the patients (n = 20) with MS had a WC above 
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Table 2: Severity of obesity by age 
Age Obese 
n = (%) 
Morbidly obese 
n = (%) 
Total 
n = (%) 
<2 years 2 (2.4) 10 (12) 12 (14.4) 
2-5 years 2 (2.4) 12 (14.5) 14 (16.9) 
6-18 years* 14 (16.9) 43 (51.8) 57 (68.7) 
Total 18 (21.7) 65 (78.3) 83 (100) 




Table 3: Distribution of MS1 by age and severity of obesity 
Age Obese 
n = (%) 
Morbidly obese 
n = (%) 
Total 
n = (%) 
<2 years 0 (0) 3 (15) 3 (15) 
2-5 years 1 (5) 2 (10) 3 (15) 
6-18 years2 3 (15) 11(55) 14 (70) 
Total 4 (20) 16 (80) 20 (100) 
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Predictive factors for Metabolic Syndrome 
Household income median showed a difference of R1473 between the group with MS 
(R3625) and those without MS (R2125).  Even though the MS group has about a 70% 
higher income, both groups still fall in the lower income class.  There was no significant 
difference of MS when comparing the different income groups (p = 0.51). 
There was no significant difference found when comparing single to multiple caregivers 
(p = 0.45).  No significant difference was found in screen time between children with 
MS and those without MS with the median being 3 hours (range = 1 – 8 hours) per day 
(p = 1.0).  MS group had a median BMI SDS of 3.45 at presentation with the non-MS 
group median being 3.0.  The BMI SDS at presentation was higher in the group with 
MS but was not found to be statistically significant (p = 0.12).  Residential area played 
no role in predicting for MS.  The majority of our patients come from low income 
communities and the patients included came from all parts of our drainage area. 
 
Table 4: Putative predictive factors for MS 
Variable p-value 
Household income 0.51 
Number of caregivers 0.45 
Screen time 1.0 








The prevalence of NAFLD in obese children 
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Of the 83 patients included, 46 (55%) had liver function testing done.  The 46 patients 
consisted of 7 obese and 39 morbidly obese children.  Of these 46 patients 29 (63%) 
had abnormal liver function results.  4 out of the 7 obese (57.1%) and 25 of the 39 
morbidly obese (64.1%) children had abnormal LFT’s.  There is no significant 
difference between the two groups. (p = 0.72) 
 
Table 5: Obesity and possible NAFLD by age 




<2 years 8 Obese 0 1 
Morbidly obese 2 5 
2-5 years 5 Obese 0 0 
Morbidly obese 1 4 
6-18 years* 33 Obese 3 3 
Morbidly obese 11 16 
*Possible NAFLD in 5 adolescents: 2 obese and 3 morbidly obese 
 
Predictive factors for possible NAFLD  
Of the 83 patients included in the study 29 had possible NAFLD.There was no 
significant difference between the possible NAFLD group and the group with normal 
LFTs regarding hypertension (p = 0.65) and dyslipidaemia (p = 0.45).  Insulin 
resistance, assessed as abnormal high fasting glucose, could not be demonstrated 
possibly due to limited number of patients that had the test done. 
Waist circumference (WC) however did show a relationship with possible NAFLD but 
was also not statistically significant.  68 (82%) of the 83 patients in the study had a 
WCrecorded.  Of these 66 (97%) were above the 90th percentile.   
Only 44 of the 66 patients with a WC >90th percentile had LFT results available and of 
these 28 (63%) had abnormal LFTs and thus possible NAFLD. 
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Of the 29 patients in the study with possible NAFLD 26 (89%) had a WC>90th 
percentile.  
44 patients that had all necessary parameters measured in order to make the diagnosis 
of MS.  9 patients (45%) with MS had possible NAFLD and 15 patients (62%) without 
MS had possible NAFLD. There was no significant difference between the two groups 
(p = 0.31). 
 
Relationship between MS and possible NAFLD 
Of the 29 patients with deranged liver enzymes 4 (14%) were obese and 25 (86%) 
morbidly obese.  Possible NAFLD occurred in 57% of obese and 66% of morbidly 
obese patients suggesting that there may not be a significant relationship between the 
severity of obesity and NAFLD.  This relationship was not formally evaluated in this 
study.  Of the 29 patients with possible NAFLD only 9 (31%) were diagnosed to have 
MS (Table 6).  This difference is not statistically significant (p = 0.3). 
 
Table 6: MS and possible NAFLD by age 
Age MS with possible 
NAFLD  
n = (%) 
MS without 
possible NAFLD 
n = (%) 
Total 
n = (%) 
<2 years 2 (10) 1 (5) 3 (15) 
2-5 years 0 (0) 3 (15) 3 (15) 
6-18 years* 7 (35) 7 (35) 14 (70) 
Total 9 (45) 11 (55) 20 (100) 
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Effectiveness of intervention 
Changes in the BMI SDS of the 83 patients in this study were as follows: 48 (57.8%) 
decreased, 12 (14.5%) increased and 23 (27.7%) remained unchanged.  Factors 
predicting a favourable outcome following interventions to manage the patient’s obesity 
was investigated (Table 7).  Figure 2 shows age at booking visit compared to changes 
in BMI SDS as an interval plot depicting 95% confidence intervals.  The younger 
patients showed a decrease in BMI SDS which was clinically significantly different 
when compared to the older group of patients that showed an increase in their BMI 
SDS.  The variable ‘age of first visit’ was approaching significance (p = 0.08).  The 
duration of follow-up was significant (p = 0.01).  A longer follow-up duration showed 
improved outcome with decrease in BMI SDS.  Follow-up duration ranged from 3 
months to 6.42 years (mean = 1.5 years).  Figure 3 shows duration of follow-up 
compared to changes in BMI SDS depicted in a box-and-whisker plot.   BMI SDS at 
presentation was also significant (p = 0.01).  The initial BMI SDS was higher in the 
group that showed a decrease in BMI SDS.  The mean BMI SDS in the group that 
showed a decrease in BMI SDS was 3.3.  This was significantly higher than the mean 
BMI SDS of 2.8 found in the study group where the BMI SDS increased or remained 
unchanged. 
Household income (p = 0.71), screen time (p = 0.77), caregiver (p = 0.94), number of 
siblings (p = 0.14), number of dietician visits (p = 0.17), presence of MS (p = 0.05) and 
the number of times the patient was seen by the paediatric endocrinologist when 
compared to the paediatric registrar was not related to the effectiveness of the 
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Table 7: Factors predicting a decrease in BMI SDS 
Variable p-value 
Household income 0.71 
Number of caregivers 0.94 
Number of siblings 0.14 
Screen time 0.77 
Seen by endocrinologist vs registrar 0.16 
Number of dietician visits 0.17 
Metabolic syndrome 0.05 
Initial BMI SDS 0.01* 
Age of first visit 0.08 





Fig. 2: Effectiveness of intervention – Age at booking versus BMI SDS change 













n = (%) 
BMI SDS 
increase 
n = (%) 
BMI SDS 
unchanged 
n = (%) 
<6 months 8 (16.7) 2 (16.6) 15 (65.2) 
6 months – 1 year 10 (20.8) 5 (41.7) 7 (30.5) 
>1 year 30 (62.5) 5 (41.7) 1(4.3) 
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Chapter 6: Discussion 
 
There are a number of studies reporting the prevalence of obesity in LMIC which varies 
from 6.7% to 19.3%. [4,5,25]  The trend in LMIC is following the trends previously 
reported in high income countries but the rate of increase in obesity is currently higher 
in LMIC while the rates of increase in obesity seem to be plateauing in developed 
countries. [25] In spite of these many reports on the rising prevalence of obesity in 
children in LMIC there are few reports of the prevalence of MS and NAFLD occurring 
in these populations.MS and NAFLD are strongly associated with obesity and these 
entities have been widely reported in the obese population of high income countries.  
This study only looked at obese patients in a hospital setting.  In the study group used 
21.7% were obese and 78.3% morbidly obese.  This difference is likely due to our clinic 
being a referral unit and morbid obesity is more likely to be referred. 
 
MS occurred in 28.5% of obese and 53.3% of morbidly obese children and it was 
significantly more common in children with morbid obesity (p<0.001).  This is in keeping 
with international data.  A USA based study demonstrated MS prevalence in 38.7% of 
obese and 49.7% of morbidly obese children and adolescence aged 4 to 20 years.  
The USA study also found that each half-unit increase in the Z score for the BMI was 
associated with a significant increase in the risk of the MS (odds ratio, 1.55; 95 percent 
confidence interval, 1.16 to 2.08). [13] This study thus confirms that MS occurs in 
obese children in our setting. 
 
Possible NAFLD occurred in 63% of the patients in our study. This is in keeping with 
international results from the USA where the prevalence of NAFLD was found to be 
60% in obese and 90% in morbidly obese adults at autopsy. [19] There was no 
significant difference in the prevalence of NAFLD demonstrated between the obese 
(57.1%) and morbidly obese (64.1%) children and adolescents in our study.  In patients 
with MS 45% had possible NAFLD.  The true prevalence of paediatric NAFLD in the 
community is not known.  International studies also using transaminase as diagnosis 
for possible NAFLD found a prevalence of 29% in obese children, but when using lower 
cut-off limits for ALT (from the SAFETY study) the prevalence of possible NAFLD 
increased to 63%. [17,19] Some studies in developed countries i.e. USA have reported 
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prevalence of possible NAFLD as high as 70% to 80% in obese children. [27] In the 
current study the correlation was higher when comparing possible NAFLD with obesity 
and an increased WC than it was comparing possible NAFLD with MS.  Of the patients 
with possible NAFLD 89% had a WC>90th percentile.  Of the patients with possible 
NAFLD 14% were obese and 86% morbidly obese.  Only 31% of patients with possible 
NAFLD also had MS. 
 
Confirming NAFLD by liver biopsy is not feasible in either developed or developing 
countries. For this reason, non-invasive diagnostic screening tests have been 
proposed and are widely used, indicating possible NAFLD.  As with MS, it is worrying 
that NAFLD has not been widely reported from LMIC.  The implications for health 
service delivery in these resource limited countries have not been considered.  The 
development of non-invasive tests with high specificity and sensitivity for NAFLD would 
be important.  In our setting cost and availability are limiting factors.  Ultrasound 
techniques such as the hepatorenal index together with the use of liver function testing 
might be a viable option in the future and should be studied in our setting. [23] 
 
In most studies MS and NAFLD are not considered in young children. In this study 3 
out of 9 (33%) of the children younger than 2 years of age fulfilled the criteria allowing 
for the diagnosis of MS to be made.  Similarly in this age group 5 out of 7 (71%) met 
the criteria of possible NAFLD. This might indicate that these complications occur in 
younger children in our setting.  This worrying observation needs further investigation 
and demonstrates the need for early intervention in young children who are obese and 
referral where indicated. 
 
Factors predicting the presence of MS and NAFLD were assessed.  Demonstrating 
predictive factors can help with improving and planning future interventions.  In this 
study we were unable to confirm any suspected risk factors that predicted the presence 
of MS.  A higher BMI SDS at presentation was found in the group with MS but was not 
statistically significant.  This might be due to the small sample size.  Similarly, we were 
unable to demonstrate risk factors that predicted for NAFLD.  This is also likely due to 
the small sample size especially in the younger age range.  MS was not found to be a 
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predictor of possible NAFLD but of note is that of the patients with a WC>90th 
percentile, 63% had possible NAFLD. 
 
This study did demonstrate duration of follow-up and initial BMI to be significant 
predictive factors for weight loss following lifestyle intervention.  This is in keeping with 
international data from Australia and the UK that the outcome is better when obese 
children are followed up for more than 6 months after implementation of the 
management interventions [28].  In our study 83.3% of patients that were followed up 
for >1 year showed a decrease in BMI SDS as compared to 38.2% who followed up 
for<1 year.   
 
The age of presentation was approaching significance when comparing the group that 
demonstrated a change in BMI compared to the unchanged and increased BMI groups.  
But if only the ‘increase in BMI SDS’ group is compared to the ‘decrease in BMI’ group 
there is a significant difference between the groups as shown in Figure 2.  This study 
suggests that there is an increased chance of success in the patients that present at 
<8 years of age.  If the patient presented for the first time over the age of 8 years they 
either maintain or even increase their BMI SDS. 
 
There were certain factors for predicting a favorable outcome following intervention 
that were expected to be significant, but in the current study were not.  The small 
number of patients in the study was most likely the reason for this.  Another reason for 
screen time not being significant could be due to patients underestimating the actual 
time spent using electronic devices.  Income is confounded by the fact that all the 
patients come from the same socio-economic class. The number of dietician visits and 
number of times seen by the endocrinologist were also not found to be statistically 
significant but can be explained.  Almost all the patients were seen by a dietician at 
least once and got the necessary education.  Dietary input would most likely also have 
been given by the doctor.  These patients were all also seen at least once by the 
endocrinologist and/or got discussed with him on most visits if seen by a doctor in 
training. The endocrinologist would then assist the doctor in decision making and 
management of the patients.  This likely contributes to the finding of no significance of 
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these factors.  Decrease in BMI SDS was more likely with a higher initial BMI and this 
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Chapter 7: Conclusion 
 
The prevalence of MS and NAFLD in this study is in keeping with international data 
suggesting that these complications of obesity are as common in our setting as 
reported worldwide. MS was more common in morbidly obese children.  Even children 
< 2 years met the criteria of MS and possible NAFLD.  Prevalence of possible NAFLD 
using elevated liver enzymes as a screening tool was similar to international data 
suggesting that we can continue using this practice.  Lower cut-off limits might need to 
be implemented.  Although not reaching significance, possible NAFLD seemed to be 
more closely associated with obesity and increased waist circumference than with MS.  
Children referred and treated before 8 years and followed-up for >1 year are more 
likely to show a decrease in BMI.  With the increasing numbers of obese children it is 
impossible to treat all these patients in a tertiary clinic.  They should ideally be treated 
at their local health institutions.  It is time consuming and a multidisciplinary approach 
is needed.  This is not feasible for many parts of our drainage area at present. 
 
Recommendation: 
All children and adolescent patients who are obese should be screened for MS and 
NAFLD. Early referral and a prolonged management period are needed in order to 
achieve decrease in BMI SDS.  A bigger study to investigate whether WC is a suitable 
screening tool for NAFLD in our setting is needed.  As liver enzymes are not specific 
for NAFLD, additional methods to detect NAFLD like ultrasound and hepatorenal index 
should also be used.  A large community based study to establish true prevalence of 
MS and NAFLD in obese children of the community should be done.  This study can 
also be used to establish predictive factors for both entities. How obesity is managed 
at primary and secondary level should be reviewed and efforts to prevent the scourge 
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Case recording form 
1. Patient name and folder number 
2. Patient case number 
3. Date of birth (DD/MM/YEAR); Age 
4. Gender (M/F) 
5. Race (W/C/B/O) 
6. Height (m) 
7. Weight (kg) 
8. BMI 
9. BMI SDS 
10. BMI (Increase/Decrease) 
11. Waist circumference (cm) 
12. Blood pressure (mm Hg) 
13. Triglycerides (mmol/L) 
14. HDL (mmol/L) 
15. Fasting glucose (mmol/L) 
16. ALT (U/l) 
17. AST (U/l) 
18. GGT (U/l) 
19. Metabolic syndrome (Y/N) 
20. NAFLD (Y/N) 
21. Dietician (Y/N)  
– no of visits 
22. Endocrinologist (Y/N) 
-no of visits 
23. Duration of follow-up 
24. No of visits to tertiary centre 
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